Tasso Partners and Dana Carrera Report 14.3% Passive Stake in PAVmed Inc. (PAVM)

On April 3, 2026, Tasso Partners, LLC and Dana Carrera filed an amended Schedule 13G (Amendment No. 1) regarding their stake in PAVmed Inc. (PAVM). The reporting persons disclosed a combined beneficial ownership of 14.3% of the company's common stock. Specifically, Tasso Partners, LLC directly holds 912,996 shares, while Dana Carrera is deemed to beneficially own a total of 914,246 shares, which includes the shares held by Tasso Partners and an additional 1,250 shares held personally. This ownership level is based on 6,383,089 shares outstanding as of March 27, 2026. Dana Carrera exercises control over Tasso Partners through Tasso Capital, LLC. The filing was made pursuant to Rule 13d-1(c), indicating a passive investment intent with no purpose of influencing or changing the control of the issuer. The principal business office for the reporting persons is located in Rumson, New Jersey. This amendment represents a significant holding in the medical technology company.